drugset / Trial / NCT01189760
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides)
Timeline
- Start
- 2010-09-01
- Primary completion
- 2011-03-01
- Completion
- 2011-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 24 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 44 iu | — |
Indications
No indication recorded.